Topical isotretinoin (Timber Pharmaceuticals)

N/A

Report date: 2026/05/23 20:00:57

Base Information

Drug NameTopical isotretinoin (Timber Pharmaceuticals)
Drug Alias NameTMB-001 (Timber Pharmaceuticals)
ClassificationSmall molecules
Mechanisms of ActionRetinoic acid receptors agonists
TargetsRetinoic acid receptors
Therapy Area/IndicationsIchthyosisChemical and Drug Induced Liver Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesItaly +[6] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPatagonia Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesTimber Pharmaceuticals IncLeo Pharma Inc
Inactive CompaniesN/A
Active IndicationsIchthyosisChemical and Drug Induced Liver Injury
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A